argipressin, beta-mercapto-beta,beta cyclopentamethylenepropionic acid(1)- has been researched along with cardiovascular agents in 1 studies
| Studies (argipressin, beta-mercapto-beta,beta cyclopentamethylenepropionic acid(1)-) | Trials (argipressin, beta-mercapto-beta,beta cyclopentamethylenepropionic acid(1)-) | Recent Studies (post-2010) (argipressin, beta-mercapto-beta,beta cyclopentamethylenepropionic acid(1)-) | Studies (cardiovascular agents) | Trials (cardiovascular agents) | Recent Studies (post-2010) (cardiovascular agents) |
|---|---|---|---|---|---|
| 33 | 0 | 0 | 17,645 | 1,480 | 6,891 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bemana, I; Kagawa, M; Nagao, S | 1 |
1 other study(ies) available for argipressin, beta-mercapto-beta,beta cyclopentamethylenepropionic acid(1)- and cardiovascular agents
| Article | Year |
|---|---|
Arginine vasopressin receptor antagonists for treatment of vasogenic brain edema: an experimental study.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Body Water; Brain Chemistry; Brain Edema; Cardiovascular Agents; Cerebrovascular Disorders; Cold Temperature; Injections, Intraventricular; Male; Rats; Rats, Sprague-Dawley | 1996 |